Lysolecithin-dependent release of cholesterol from rat plasma.
We studied the effect of lysolecithin on the clearing of plasma cholesterol. The immediate and maximal conversion of plasma lecithin to lysolecithin was produced in rats by intravenous injection of phospholipase A. The changes which took place in the converted lysolecithin and of cholesterol were followed in rats which had previously received [32-P]phosphate and [14-C]cholesterol. We followed simultaneously the in vitro changes in blood removed immediately after the in vivo administration of phospholipase A. The experiments showed that a substantial part of the plasma lecithin was converted to lysolecithin within the first minute after intravenous administration of phospholipase A. In the course of 60 min of blood incubation, the ratio of plasmatic lysolecithin in the closed system continued to increase. At the same time the content of cholesterol also increased. In vivo, the converted lysolecithin was quickly released from the plasma, so that within 10 min the original lecithin content dropped to 15-5% depending on the dose of phospholipase A that had been administered. The content of sphingomyelin and lysolecithin, which increased only temporarily shortly after injection, did not alter during the experiment. The level of plasma cholesterol esters, however, dropped significantly, whereas the free cholesterol content increased. The molar ratio of the drop in lipid phosphorus and cholesterol esters in plasma after the administration of phospholipase A was similar. A significantly higher cholesterol content was found in the liver of animals treated with phospholipase A.